Title:
SUSPENSION AGENT
Document Type and Number:
Japanese Patent JP2016079187
Kind Code:
A
Abstract:
PROBLEM TO BE SOLVED: To provide a cancer vaccine formulation that comprises peptides obtained by modifying WT1 protein-derived cancer antigen peptides, and has improved suspension stability.SOLUTION: A pharmaceutical composition for injection comprises following components: (a) one or more peptides selected from peptides comprising an amino acid sequence represented by Cys-Tyr-Thr-Trp-Asn-Gln-Met-Asn-Leu, peptides represented by formula (1), peptides represented by formula (2), or salts thereof, and (b) anionic polymers.SELECTED DRAWING: Figure 1
Inventors:
ONITA MAIKO
Application Number:
JP2015207200A
Publication Date:
May 16, 2016
Filing Date:
October 21, 2015
Export Citation:
Assignee:
DAINIPPON SUMITOMO PHARMA CO
International Classes:
A61K38/00; A61K9/08; A61K9/19; A61K47/10; A61K47/26; A61K47/36; A61K47/38; A61P35/00; A61P37/04
Domestic Patent References:
| JP2010540671A | 2010-12-24 | |||
| JP2009534392A | 2009-09-24 |
Foreign References:
| WO2004024175A1 | 2004-03-25 | |||
| WO2007063903A1 | 2007-06-07 | |||
| WO2004063217A1 | 2004-07-29 |
Other References:
医薬品添加物事典, vol. 第１刷, JPN6019027059, 2007, pages 14 - 20, ISSN: 0004075108
Attorney, Agent or Firm:
Takashima Ichi
Kyoko Doi
Mitsunori Kamata
Yaeko Tamura
Murata Miyuki
Junzo Koike
Hirofumi Toma
Kyoko Doi
Mitsunori Kamata
Yaeko Tamura
Murata Miyuki
Junzo Koike
Hirofumi Toma